학술논문

EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 73,683건 | 목록 1~20
Academic Journal
Tomita Y; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Department of Neurosurgery and Neuroendovascular Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.; Link G; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.; Ge Y; The Jack Martin Fund Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children's Hospital, New York, New York, United States of America.; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Gold ERH; The Jack Martin Fund Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children's Hospital, New York, New York, United States of America.; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Racanelli A; The Jack Martin Fund Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children's Hospital, New York, New York, United States of America.; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Cardona HJ; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Romero M; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Gadd S; Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.; Watanabe J; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Uchida E; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Hashizume R; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Division of Hematology-Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Division of Pediatric Hematology-Oncology, Children's of Alabama, Birmingham, Alabama, United States of America.; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.; Takata N; Center for Vascular and Developmental Biology, Feinberg Cardiovascular and Renal Research Institute, Northwestern University, Chicago, Illinois, United States of America.; Simpson Querrey Institute for BioNanotechnology, Northwestern University, Chicago, Illinois, United States of America.; Pinero G; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, United States of America.; Hambardzumyan D; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, United States of America.; Spasojevic I; Department of Medicine - Oncology, Duke University School of Medicine and PK/PD Core Laboratory, Duke Cancer Institute, Durham, North Carolina, United States of America.; Hu G; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States of America.; Hennika T; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, United States of America.; Genentech, Inc., South San Francisco, California.; Brat DJ; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; Green AL; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.; Becher OJ; Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.; The Jack Martin Fund Division of Pediatric Hematology-Oncology, Mount Sinai Kravis Children's Hospital, New York, New York, United States of America.; Department of Oncological Sciences, Mount Sinai Health System, New York, New York, United States of America.; Division of Hematology-Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States of America.; Department of Biochemistry and Molecular Genetics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Nakano E; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Kage Y; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Ogata D; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE
Academic Journal
Saha A; Department of Oncology, Apollo Multi-speciality Hospitals, Kolkata, India.; Raja T; Department of Medical Oncology, Apollo Speciality Cancer Hospital, Chennai, India.; Dutt Dwary A; Department of Oncology, Apollo Multi-speciality Hospitals, Kolkata, India.; Ghosh I; Department of Oncology, Apollo Multi-speciality Hospitals, Kolkata, India.; Narayan Mahapatra P; Department of Oncology, Apollo Multi-speciality Hospitals, Kolkata, India.; Mukhopadhay T; Department of Oncology, Apollo Multi-speciality Hospitals, Kolkata, India.
Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Academic Journal
Nakajima I; Department of Ophthalmology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Yoshino K; Department of Dermatologic Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.; Tsuji H; Department of Ophthalmology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 8610759 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5205 (Electronic) Linking ISSN: 08820538 NLM ISO Abbreviation: Semin Ophthalmol Subsets: MEDLINE
Academic Journal
Petrini I; Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.; Giaccone G; Weill-Cornell Medicine, Meyer Cancer Center, New York, NY, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE
Academic Journal
Mullins KR; James L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, Ohio, USA.; Guo JJ
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE
Academic Journal
Ogino A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Vajdi A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Mu XJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Mahadevan NR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Ngo K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Booker MA; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cejas P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, and.; Okoro JJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Xu M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Springer BF; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Eschle BK; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Messier CM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Wang S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Syamala S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, and.; Tamen RM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Adeni AE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Chambers ES; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Canadas I; Blood Cell Development and Function Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.; Thai T; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Christensen CL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Xu C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Lizotte PH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Oxnard GR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Watanabe H; Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine.; Tisch Cancer Institute; and.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Long HW; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Center for Functional Cancer Epigenetics, and.; Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.; Tolstorukov MY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Belfer Center for Applied Cancer Science.; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Academic Journal
Saray S; Department of Medical Oncology, Balıkesir Ataturk State Hospital, Balıkesir, Turkey.; Hızlı P; Department of Dermatology, Faculty of Medicine, Balikesir University, Balikesir, Turkey.
Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Academic Journal
Subramanian C; Department of Surgery, and Biomedical and Translational Sciences, Carle Illinois College of Medicine at the University of Illinois Urbana Champaign, Urbana, Illinois, USA.; Hohenberger KK; Department of Otolaryngology, Stanford Medicine, Stanford, California, USA.; Zuo A; Department of Pharmacology, University of Notre Dame, Notre Dame, Indiana, USA.; Cousineau E; Department of Surgery, and Biomedical and Translational Sciences, Carle Illinois College of Medicine at the University of Illinois Urbana Champaign, Urbana, Illinois, USA.; Blagg B; Department of Pharmacology, University of Notre Dame, Notre Dame, Indiana, USA.; Cohen M; Department of Surgery, and Biomedical and Translational Sciences, Carle Illinois College of Medicine at the University of Illinois Urbana Champaign, Urbana, Illinois, USA.; Beckman Institute for Advanced Science and Technology, University of Illinois Urbana-Champaign, Urbana, Illinois, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print Cited Medium: Internet ISSN: 1582-4934 (Electronic) Linking ISSN: 15821838 NLM ISO Abbreviation: J Cell Mol Med Subsets: MEDLINE
Academic Journal
Tak E; Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; An HI; Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Lee AS; Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Han K; Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Choi J; Department of Convergence Medicine, Asan Medical Institute of Convergence Science and Technology (AMIST), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Kim HD; Department of Oncology, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.; Hong YS; Department of Oncology, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.; Kim SY; Department of Oncology, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.; Choi EK; Department of Radiation Oncology, Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Kim JE; Department of Oncology, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea. jeongeunkim@amc.seoul.kr.; Kim TW; Department of Oncology, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, 05505, Republic of Korea.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] MEK inhibitor
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어